The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Open accessAbstract
Lipid homeostasis in vertebrate cells is regulated by a family of membrane-bound transcription factors designated sterol regulatory element-binding proteins (SREBPs).SREBPs directly activate the expression of more than 30 genes dedicated to the synthesis and uptake of cholesterol, fatty acids, triglycerides, and phospholipids, as well as the NADPH cofactor required to synthesize these molecules (1-4).In the liver, three SREBPs regulate the production of lipids for export into the plasma as lipoproteins and into the bile as micelles.The complex, interdigitated roles of these three SREBPs have been dissected through the study of ten different lines of gene-manipulated mice.These studies form the subject of this review.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By contrast, Srebp-1c is transcribed at extremely high levels in response to insulin (6, 28)”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As SREBPs contain an SRE in their promoter region, they induce their own expression in a positive feedback mechanism4,18.”
From Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism (2020) · cites this paper as [4]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“An additional level of regulation of the genes involved in cholesterol uptake and synthesis is provided by SREBP signaling, in which low cellular sterol levels lead to the SCAP-mediated trafficking of SREBP proteins from the ER to the Golgi, where they are cleaved by resident proteases (encoded by MBTPS1 and MBTPS2) to release and activate their transcription factor domains[7,8].”
From Genome-scale CRISPR screening for modifiers of cellular LDL uptake (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“likely due to overlapping functions allowing one gene to compensate for loss of the other[7]”
From Genome-scale CRISPR screening for modifiers of cellular LDL uptake (2021) · cites this paper as [7]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Two transcription factor families with opposing actions – the liver-X receptors (LXRs) and the sterol regulatory element-binding proteins (SREBPs) – are the main orchestrators of this balance (Hong and Tontonoz, 2014; Horton et al., 2002).”
From Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP (2017) · cites this paper as Horton et al., 2002
Experimental — accuracy not yet measured
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In the liver, SREBP1c is the prominent SREBP1 isoform and primarily controls fatty acid synthesis and mobilization, while SREBP2 controls cholesterol biosynthesis and lipoprotein uptake [12,13].”
From Loss of the E3 ubiquitin ligase MARCHF6 alters hepatic lipid metabolism and drives spontaneous hepatosteatosis (2026) · cites this paper as [12]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The intracellular cholesterol economy is largely regulated by the sterol response element binding protein (SREBPs), a group of transcription factors that regulate genes involved in the biosynthesis of cholesterol and fatty acids (13).”
From The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders (2011) · cites this paper as [13]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP1a and SREBP1c are responsible for fatty acid metabolism and SREBP2 primarily for cholesterol synthesis through increasing the expression of HMG-CoA reductase (HMGCR) [32].”
From HIV-TAT dysregulates microglial lipid metabolism through SREBP2/miR-124 axis: Implication of lipid droplet accumulation microglia in NeuroHIV (2025) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“However, SREBPs not only activate cholesterol synthesis but also fatty acid and phospholipid synthesis (2).”
From Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* (2010) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“Genes involved in its synthesis are coordinately up-regulated by the action of SREBP transcription factors (2).”
From Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* (2010) · cites this paper as [2]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP-1c regulates the transcription of genes involved in fatty acid metabolism, such as fatty acid synthase (FASN) (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“SREBP-2 regulates the transcription of cholesterol-related genes, such as 3-hydroxy-3-methylglutaryl CoA reductase (HMGCR), which catalyzes a rate-limiting step in cholesterol biosynthesis, and the low-density lipoprotein receptor (LDLr), which imports cholesterol from the blood (5–7).”
From miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling (2011) · cites this paper as [6]
The cited source says what the claim attributes to it.
In the citing paper
“The sterol-regulatory element binding proteins (SREBP) are central transcriptional regulators of lipid metabolism.”
From Haploid genetic screens identify SPRING/C12ORF49 as a determinant of SREBP signaling and cholesterol metabolism (2020) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The SREBP pathway is activated when cellular cholesterol levels decline as a means to increase cholesterol synthesis and uptake (4).”
From A MARCH6 and IDOL E3 Ubiquitin Ligase Circuit Uncouples Cholesterol Synthesis from Lipoprotein Uptake in Hepatocytes (2016) · cites this paper as [4]
The cited source says what the claim attributes to it.
In the citing paper
“The released N-terminal SREBP-1 and −2 transcriptional domains translocate to the nucleus to activate transcriptional programs that promote fatty acid and cholesterol biosynthesis, respectively8.”
From Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans (2023) · cites this paper as [8]
In the citing paper
“The cellular signal driving this increased hepatic de novo lipogenesis can most likely be attributed to hyperinsulinemia promoting increased expression of the sterol regulatory element binding protein-1c in the liver, which coordinately regulates transcription of all of the key enzymes involved in lipogenesis (24).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [24]
In the citing paper
“Recently, 2 additional transcription factors, X-box binding protein 1 (XBP1) and CHO response element-binding protein (ChREBP), have been identified as inducers of hepatic lipogenesis in response to ingested CHOs (eg, fructose and glucose) that is independent of insulin.431,432”
From Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association (2011) · cites this paper as [431]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Role of AMP-Activated Protein Kinase in Mechanism of Metformin Action
Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13505 · Cited by 5,652
Brown, M. S., & Goldstein, J. L. (1997) · Cell · doi:10.1016/s0092-8674(00)80213-5 · Cited by 3,834
Self-citationNonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Repa, J. J., Liang, G., Ou, J., Bashmakov, Y. K., Lobaccaro, J. A., Shimomura, I., Shan, B., Brown, M. S., Goldstein, J. L., & Mangelsdorf, D. J. (2000) · Genes & Development · doi:10.1101/gad.844900 · Cited by 1,724
Self-citationLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Self-citationStructural requirements of ligands for the oxysterol liver X receptors LXRα and LXRβ
Janowski, B. A., Grogan, M. J., Jones, S. A., Wisely, G. B., Kliewer, S. A., Corey, E. J., & Mangelsdorf, D. J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.266 · Cited by 946
Shimomura, I., Matsuda, M., Hammer, R. E., Bashmakov, Y. K., Brown, M. S., & Goldstein, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00010-9 · Cited by 860
Self-citationShimano, H., Horton, J. D., Hammer, R. E., Shimomura, I., Brown, M. S., & Goldstein, J. L. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118951 · Cited by 817
Self-citationJoseph, S. B., Laffitte, B. A., Patel, P. H., Watson, M. A., Matsukuma, K. E., Walczak, R., Collins, J. L., Osborne, T. F., & Tontonoz, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m111041200 · Cited by 795
Kim, J. B., Sarraf, P., Wright, M., Yao, K., Mueller, E., Solanes, G., Lowell, B. B., & Spiegelman, B. M. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1411 · Cited by 792
Cited by
Sorted by citations
Items 901–1,000 of 1,040
Glimcher, L. H., & Lee, A. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04956.x · Cited by 82
Murphy, C., Parini, P., Wang, J., Björkhem, I., Eggertsen, G., & Gåfvels, M. E. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2005.06.001 · Cited by 81
Wang, Y., Muneton, S., Sjövall, J., Jovanovic, J. N., & Griffiths, W. J. (2008) · Journal of Proteome Research · doi:10.1021/pr7006076 · Cited by 83
Adipogenesis of bovine perimuscular preadipocytes
Taniguchi, M., Guan, L. L., Zhang, B., Dodson, M. V., Okine, E. K., & Moore, S. S. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.11.110 · Cited by 81
Zheng, W., Mast, N., Saadane, A., & Pikuleva, I. A. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m053439 · Cited by 81
MicroRNAs regulating lipid metabolism in atherogenesis
Rayner, K. J., Fernandez-Hernando, C. F., & Moore, K. J. (2012) · Thrombosis and Haemostasis · doi:10.1160/th11-10-0694 · Cited by 84
Shi, H., Luo, J., Yao, D., Zhu, J., Xu, H., Shi, H., & Loor, J. J. (2013) · Journal of Dairy Science · doi:10.3168/jds.2013-7105 · Cited by 81
Biosynthesis of the regulatory oxysterol, 5-cholesten-3β,25-diol 3-sulfate, in hepatocytes
Li, X., Pandak, W. M., Erickson, S. K., Ma, Y., Yin, L., Hylemon, P. B., & Ren, S. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700301-jlr200 · Cited by 81
Song, Y., Luo, Z., Zhang, L.-H., Högstrand, C., & Pan, Y. (2015) · Chemosphere · doi:10.1016/j.chemosphere.2015.11.031 · Cited by 81
PCSK9: Regulation and Target for Drug Development for Dyslipidemia
Burke, A. C., Dron, J. S., Hegele, R. A., & Huff, M. W. (2017) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104944 · Cited by 74
Sui, G.-G., Xiao, H., Lu, X., & Sun, Z. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b02696 · Cited by 83
He, M., Zhang, W., Dong, Y., Wang, L., Fang, T., Tang, W., Lv, B., Chen, G., Yang, B., Huang, P., et al. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0490-8 · Cited by 80
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
Ganbold, M., Owada, Y., Ozawa, Y., Shimamoto, Y., Ferdousi, F., Tominaga, K., Zheng, Y., Ohkohchi, N., & Isoda, H. (2019) · Scientific Reports · doi:10.1038/s41598-019-52736-y · Cited by 81
Berardo, C., Pasqua, L. G. D., Cagna, M., Richelmi, P., Vairetti, M., & Ferrigno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249646 · Cited by 89
Use of Ferulic Acid in the Management of Diabetes Mellitus and Its Complications
Li, X., Wu, J., Xu, F., Chu, C., Li, X., Shi, X., Zheng, W. L., Wang, Z., Jia, Y., & Xiao, W. (2022) · Molecules · doi:10.3390/molecules27186010 · Cited by 80
Hashimoto, K., Yamada, M., Matsumoto, S., Monden, T., Satoh, T., & Mori, M. (2006) · Endocrinology · doi:10.1210/en.2006-0116 · Cited by 80
Chávez-Santoscoy, R. A., Gutierrez-Uribe, J. A., Granados, O., Torre-Villalvazo, I., Serna-Saldivar, S. O., Torres, N., Palacios‐González, B., & Tovar, A. R. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114514001536 · Cited by 80
Dissecting the role of insulin resistance in the metabolic syndrome
Haas, J. T., & Biddinger, S. B. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32832b2024 · Cited by 82
Ravid, Z., Bendayan, M., DELVIN, E. E., Sané, A. T., Elchebly, M., Lafond, J., Lambert, M. A., Mailhot, G., & Levy, E. H. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.90376.2008 · Cited by 80
Matsusue, K., Gavrilova, O., Lambert, G. C., Brewer, H. B., Ward, J. M., Inoue, Y., LeRoith, D., & Gonzalez, F. J. (2004) · Molecular Endocrinology · doi:10.1210/me.2004-0213 · Cited by 80
Jansen, P. L. M. (2004) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-200411000-00001 · Cited by 80
Multi-tissue, selective PPARγ modulation of insulin sensitivity and metabolic pathways in obese rats
Hsiao, G., Chapman, J., Ofrecio, J. M., Wilkes, J. J., Resnik, J. L., Thapar, D., Subramaniam, S., & Sears, D. D. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00219.2010 · Cited by 82
Shukla, A., Brandsch, C., Bettzieche, A., Hirche, F., Stangl, G. I., & Eder, K. (2006) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2006.05.007 · Cited by 81
Wang, Y., Wong, R. H.-F., Tang, T., Hudak, C. S. S., Yang, D., Duncan, R. E., & Sul, H. S. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.10.028 · Cited by 80
Ma, Y., Xu, L., Rodríguez‐Agudo, D., Li, X., Heuman, D. M., Hylemon, P. B., Pandak, W. M., & Ren, S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90555.2008 · Cited by 80
Lecomte, V., Meugnier, E., Euthine, V., Durand, C., Freyssenet, D. G., Némoz, G., Rome, S., Vidal, H., & Lefai, É. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.00690-09 · Cited by 84
Paredes-Turrubiarte, G., González-Chávez, A., Pérez-Tamayo, R., Salazar-Vázquez, B. Y., Hernández, V. S., Garibay-Nieto, N., Fragoso, J. M., & Escobedo, G. (2015) · Clinical and Experimental Medicine · doi:10.1007/s10238-015-0347-4 · Cited by 79
IL-33 treatment attenuated diet-induced hepatic steatosis but aggravated hepatic fibrosis
Gao, Y., Liu, Y., Yang, M., Guo, X., Zhang, M., Li, H., Li, J., & Zhao, J. (2016) · Oncotarget · doi:10.18632/oncotarget.9259 · Cited by 79
p54nrb/NONO regulates lipid metabolism and breast cancer growth through SREBP-1A
Zhu, Z., Zhao, X., Zhao, L., Yang, H., Liu, L., Li, J., Wu, J. F., Yang, F., Huang, G., & Liu, J. (2015) · Oncogene · doi:10.1038/onc.2015.197 · Cited by 79
Distinct C/EBPα motifs regulate lipogenic and gluconeogenic gene expression in vivo
Pedersen, T. Å., Bereshchenko, O., Garcı́a-Silva, S., Ermakova, O. V., Kurz, E., Mandrup, S., Porse, B. T., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601563 · Cited by 80
Standaert, M. L., Sajan, M. P., Miura, A., Kanoh, Y., Chen, H. C., Farese, R. V., & Farese, R. V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402440200 · Cited by 79
Hypoxia aggravates non-alcoholic steatohepatitis in mice lacking hepatocellular PTEN
Piguet, A., Stroka, D., Zimmermann, A., & Dufour, J. (2009) · Clinical Science · doi:10.1042/cs20090313 · Cited by 79
Baselga‐Escudero, L., Arola‐Arnal, A., Pascual‐Serrano, A., Ribas‐Latre, A., Casanova, E., Salvadó, M. J., Arola, L., & Bladé, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069817 · Cited by 79
Sterol-mediated Regulation of Human Lipin 1 Gene Expression in Hepatoblastoma Cells
Ishimoto, K., Nakamura, H., Tachibana, K., Yamasaki, D., Ota, A., Hirano, K., Tanaka, T., Hamakubo, T., Sakai, J., Kodama, T., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.028753 · Cited by 79
Alvi, S. S., Ansari, I. A., Ahmad, M. K., Iqbal, J., & Khan, M. S. (2017) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2017.11.116 · Cited by 78
Sterol 14α-demethylase, an abundant and essential mixed-function oxidase
Waterman, M. R., & Lepesheva, G. I. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.08.118 · Cited by 79
Multi-dimensional Transcriptional Remodeling by Physiological Insulin In Vivo
Batista, T. M., García-Martín, R., Cai, W., Konishi, M., O'Neill, B. T., Sakaguchi, M., Kim, J. H., Jung, D. Y., Kim, J. K., & Kahn, C. R. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.081 · Cited by 76
A MicroRNA Linking Human Positive Selection and Metabolic Disorders
Wang, L., Sinnott-Armstrong, N., Wagschal, A., Wark, A. R., Camporez, J. P., Perry, R. J., Ji, F., Sohn, Y., Oh, J. D., Wu, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.09.017 · Cited by 81
Deng, X., Dong, Q., Bridges, D., Raghow, R., Park, E. A., & Elam, M. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2015.08.007 · Cited by 76
Lin, X., Loor, J. J., & Herbein, J. H. (2004) · Journal of Nutrition · doi:10.1093/jn/134.6.1362 · Cited by 78
Bas-Prior, J. M. D., Ricketts, M., Baiges, I., Quesada, H., Ardèvol, A., Salvadó, M. J., Pujadas, G., Blay, M., Arola, L., Bladé, C., et al. (2008) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200800054 · Cited by 78
Glycolytic genes are targets of the nuclear receptor Ad4BP/SF-1
Baba, T., Otake, H., Sato, T., Miyabayashi, K., Shishido, Y., Wang, C., Shima, Y., Kimurâ, H., Yagi, M., Ishihara, Y., et al. (2014) · Nature Communications · doi:10.1038/ncomms4634 · Cited by 78
The evolution of plasma cholesterol: Direct utility or a “spandrel” of hepatic lipid metabolism?
Babin, P. J., & Gibbons, G. F. (2008) · Progress in Lipid Research · doi:10.1016/j.plipres.2008.11.002 · Cited by 81
Insulin induction of SREBP-1c in rodent liver requires LXRα-C/EBPβ complex
Tian, J., Goldstein, J. L., & Brown, M. S. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608987113 · Cited by 80
Self-citationRu, P., Hu, P., Geng, F., Mo, X. M., Cheng, C., Yoo, J. Y., Cheng, X., Wu, X., Guo, J. Y., Nakano, I., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.07.017 · Cited by 78
Hempseed Peptides Exert Hypocholesterolemic Effects with a Statin-Like Mechanism
Zanoni, C., Aiello, G., Arnoldi, A., & Lammi, C. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02742 · Cited by 86
Shen, H., Huang, S.-Y., Kung, C.-W., Chen, S., Chen, Y., Cheng, P., Lam, K., & Lee, Y. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.02.001 · Cited by 78
Lee, K. M., Yang, S.-J., Kim, Y. D., Choi, Y. D., Nam, J. H., Choi, C. S., Choi, H.-S., & Park, C.-S. (2013) · Diabetes · doi:10.2337/db12-1030 · Cited by 77
Han, S., Jiao, J., Zhang, W., Xu, J., Wan, Z., Zhang, W., Gao, X., & Qin, L. (2015) · Scientific Reports · doi:10.1038/srep15256 · Cited by 77
Dysregulation of cardiac lipid parameters in high-fat high-cholesterol diet-induced rat model
Han, Q., Yeung, S. C., Ip, M., & Mak, J. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0905-3 · Cited by 77
Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development
Li, T., & Chiang, J. Y. L. (2024) · Pharmacological Reviews · doi:10.1124/pharmrev.124.000978 · Cited by 85
Hao, J., Chen, C., Huang, K., Huang, J., Li, J., Liu, P., & Huang, H. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.09.047 · Cited by 77
Krishan, S., Richardson, D. R., & Sahni, S. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.095810 · Cited by 80
Fatostatin blocks ER exit of SCAP but inhibits cell growth in a SCAP-independent manner
Shao, W., Machamer, C. E., & Espenshade, P. J. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m069583 · Cited by 78
Physiological Suppression of Lipotoxic Liver Damage by Complementary Actions of HDAC3 and SCAP/SREBP
Papazyan, R., Sun, Z., Kim, Y. H., Titchenell, P. M., Hill, D. A., Lu, W., Damle, M., Wan, M., Zhang, Y., Briggs, E. R., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.10.012 · Cited by 80
Fucoidan alleviates dyslipidemia and modulates gut microbiota in high-fat diet-induced mice
Liu, M., Ma, L., Chen, Q., Zhang, P., Chen, C., Jia, L., & Li, H. (2018) · Journal of Functional Foods · doi:10.1016/j.jff.2018.07.006 · Cited by 77
Prevention of Obesity and Hyperlipidemia by Heptamethoxyflavone in High-fat Diet-induced Rats
Feng, K., Zhu, X., Chen, T., Peng, B., Lu, M., Zheng, H., Huang, Q., Ho, C., Chen, Y., & Cao, Y. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b05632 · Cited by 77
Holanda, D. M., Yiannikouris, A., & Kim, S. W. (2020) · Toxins · doi:10.3390/toxins12080504 · Cited by 76
Saito, Y., Yin, D., Kubota, N., Wang, X., Filliol, A. A., Remotti, H. E., Nair, A., Fazlollahi, L., Hoshida, Y., Tabas, I. A., et al. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.02.043 · Cited by 82
Dysregulation of Lipid and Glucose Metabolism in Nonalcoholic Fatty Liver Disease
Bhat, N., & Mani, A. (2023) · Nutrients · doi:10.3390/nu15102323 · Cited by 85
Seon, L. J., Adachi, Y., Takahashi, Y., & Ide, T. (2007) · British Journal Of Nutrition · doi:10.1017/s0007114507252699 · Cited by 76
Li, S., Oh, Y.-T., Yue, P., Khuri, F. R., & Sun, S.-Y. (2015) · Oncogene · doi:10.1038/onc.2015.123 · Cited by 76
The UPS and downs of cholesterol homeostasis
Sharpe, L. J., Cook, E. C. L., Zelcer, N., & Brown, A. J. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.08.008 · Cited by 74
PPARα in the pathogenesis of fatty liver disease
Rao, S. M., & Reddy, J. K. (2004) · Hepatology · doi:10.1002/hep.1840400405 · Cited by 76
Lee, J. P., Brauweiler, A., Rudolph, M., Hooper, J. E., Drabkin, H. A., & Gemmill, R. M. (2010) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0491 · Cited by 76
Human nutrigenomics of gene regulation by dietary fatty acids
Afman, L. A., & Müller, M. M. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.11.005 · Cited by 78
Macchi, C., Banach, M., Corsini, A., Sirtori, C., Ferri, N., & Ruscica, M. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319831500 · Cited by 78
Targeting n-3 Polyunsaturated Fatty Acids in Non-Alcoholic Fatty Liver Disease
Valenzuela, R., Ortíz, M., Hernández‐Rodas, M. C., Echeverría, F., & Videla, L. A. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867326666190410121716 · Cited by 75
Mahpour, A., & Mullen, A. C. (2020) · JHEP Reports · doi:10.1016/j.jhepr.2020.100177 · Cited by 75
SREBP signaling is essential for effective B cell responses
Luo, W., Adamska, J. Z., Li, C., Verma, R., Liu, Q., Hagan, T., Wimmers, F., Gupta, S., Feng, Y., Jiang, W., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01376-y · Cited by 74
Liu, X., Xin, D. E., Zhong, X., Zhao, C., Li, Z., Zhang, L., Dourson, A. J., Lee, L., Mishra, S. V., Bayat, A. E., et al. (2024) · Cell · doi:10.1016/j.cell.2024.04.005 · Cited by 80
Interplay between cholesterol and drug metabolism
Režen, T., Rozman, D., Pascussi, J., & Monostory, K. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2010.05.014 · Cited by 77
Mastrocola, R., Collino, M., Nigro, D., Chiazza, F., D’Antona, G., Aragno, M., & Minetto, M. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119587 · Cited by 77
SIRT3 reduces lipid accumulation via AMPK activation in human hepatic cells
Shi, T., Fan, G. Q., & Shu Dong, X. I. A. O. (2010) · Journal of Digestive Diseases · doi:10.1111/j.1751-2980.2009.00416.x · Cited by 75
Ding, L., Li, J., Song, B., Xu, X., Huang, W., Zhang, B., Tang, X., Qi, M., Yang, Q., Yang, Q., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.217968 · Cited by 75
König, B., Koch, A. H., Spielmann, J., Hilgenfeld, C., Hirche, F., Stangl, G. I., & Eder, K. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.01.009 · Cited by 75
Gylling, H., Hallikainen, M., Pihlajamäki, J., Simonen, P. P., Kuusisto, J., Laakso, M., & Miettinen, T. A. (2010) · Journal of Lipid Research · doi:10.1194/jlr.p006619 · Cited by 77
Thomson, E. M., Pal, S., Guénette, J., Wade, M. G., Atlas, E., Holloway, A. C., Williams, A., & Vincent, R. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw061 · Cited by 75
Correa-Cerro, L. S., Wassif, C. A., Kratz, L., Miller, G. F., Munasinghe, J. P., Grinberg, A., Fliesler, S. J., & Porter, F. D. (2006) · Human Molecular Genetics · doi:10.1093/hmg/ddl003 · Cited by 75
Vascular Endothelial Growth Factor Activation of Sterol Regulatory Element Binding Protein
Zhou, R., Yao, M., Lee, T., Zhu, Y., Martins‐Green, M. M., & Shyy, J. Y.-J. (2004) · Circulation Research · doi:10.1161/01.res.0000139956.42923.4a · Cited by 75
Matsuzaka, T., Kuba, M., Koyasu, S., Yamamoto, Y., Motomura, K., Arulmozhiraja, S., Ohno, H., Sharma, R., Shimura, T., Okajima, Y., et al. (2019) · Hepatology · doi:10.1002/hep.30953 · Cited by 74
Sulfur-Containing Amino Acids and Lipid Metabolism
Blachier, F., Andriamihaja, M., & Blais, A. (2020) · Journal of Nutrition · doi:10.1093/jn/nxaa243 · Cited by 79
Pathogenesis of alcoholic liver disease: the role of nuclear receptors
Gyamfi, M. A., & Wan, Y. Y. (2010) · Experimental Biology and Medicine · doi:10.1258/ebm.2009.009249 · Cited by 76
Role of Krüppel-like factor 15 in PEPCK gene expression in the liver
Teshigawara, K., Ogawa, W., Mori, T., Matsuki, Y., Watanabe, E., Hiramatsu, R., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.096 · Cited by 72
Kumar, S., Sharma, M., & Tiwari, M. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.05.020 · Cited by 75
Hellard, S. L., Mühleisen, T. W., Djurovic, S., Fernø, J., Ouriaghi, Z., Mattheisen, M., Vasilescu, C., Raeder, M. B., Hansen, T. F., Strohmaier, J., et al. (2008) · Molecular Psychiatry · doi:10.1038/mp.2008.110 · Cited by 71
Lavie, L. (2008) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.2.1.75 · Cited by 75
Fatty acid desaturation and chain elongation in mammals
Miyazaki, M., & Ntambi, J. M. (2008) · Elsevier eBooks · doi:10.1016/b978-044453219-0.50009-x · Cited by 74
Wang, W., Wang, J., Zhang, H., Wu, S., & Qi, G. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00600 · Cited by 74
Fatty acid metabolism and cancer development
Chen, Y., & Li, P. (2016) · 中国科学通报：英文版 · doi:10.1007/s11434-016-1129-4 · Cited by 73
Roth, A. B., Looser, R., Kaufmann, M., & Meyer, U. (2008) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e3282f706e0 · Cited by 73
Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia
Haeusler, R. A., Han, S., & Accili, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134023 · Cited by 72
PKR-Like Endoplasmic Reticulum Kinase Is Necessary for Lipogenic Activation during HCMV Infection
Yu, Y., Pierciey, F. J., Maguire, T. G., & Alwine, J. C. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003266 · Cited by 76
MacDonald, M. L. E., Singaraja, R. R., Bissada, N., Ruddle, P., Watts, R., Karasinska, J. M., Gibson, W. T., Fiévet, C., Vance, J. E., Staels, B., et al. (2007) · Journal of Lipid Research · doi:10.1194/jlr.m700478-jlr200 · Cited by 73
Vendrame, S., Daugherty, A., Kristo, A. S., & Klimis‐Zacas, D. J. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002390 · Cited by 75
Kajikawa, S., Harada, T., Kawashima, A., Imada, K., & Mizuguchi, K. (2009) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2009.02.004 · Cited by 72
Rebholz, S. L., Jones, T., Herrick, R. L., Xie, C., Calafat, A. M., Pinney, S. M., & Woollett, L. A. (2016) · Toxicology Reports · doi:10.1016/j.toxrep.2015.11.004 · Cited by 69
Maguire, S. L., Wang, C., Holland, L. M., Brunel, F., Neuvéglise, C., Nicaud, J.-M., Zavrel, M., White, T. C., Wolfe, K. H., & Butler, G. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004076 · Cited by 69
Deciphering the roles of the constitutive androstane receptor in energy metabolism
Yan, J., Chen, B., Lu, J., & Xie, W. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.102 · Cited by 69
Inhibition of cholesterol biosynthesis through RNF145-dependent ubiquitination of SCAP
Zhang, L., Rajbhandari, P., Priest, C., Sandhu, J., Wu, X., Temel, R., Castrillo, A., de Aguiar Vallim, T. Q., Sallam, T., & Tontonoz, P. (2017) · eLife · doi:10.7554/elife.28766 · Cited by 69
Metadata
- Authors
- Horton, J. D., Goldstein, J. L., & Brown, M. S.
- Affiliations
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Horton, Jay D.
- Venue
- Journal of Clinical Investigation
- Published
- 2002-05-01
- Volume
- 109
- Issue
- 9
- Pages
- 1125-1131
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W4252021281
- Cited by
- 4,092
- References
- 47
- Citations by year
- 2026: 149 · 2025: 178 · 2024: 191 · 2023: 215 · 2022: 211 · 2021: 210 · 2020: 263 · 2019: 217 · 2018: 212 · 2017: 206 · 2016: 199 · 2015: 180 · 2014: 184 · 2013: 180 · 2012: 142
- FWCI
- 104.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Funders
- W. M. Keck Foundation
- American Heart Association
- National Institutes of Health (HL20948)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- SREBP, cholesterol biosynthesis, fatty acid synthesis, lipid homeostasis, liver, transcription factors, NADPH, triglyceride synthesis, phospholipid synthesis, bile micelles, knockout mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
